Javascript must be enabled to continue!
Abstract POSTER-BIOL-1314: Investigating fatty acid beta-oxidation in ovarian cancer cells
View through CrossRef
Abstract
Purpose: To investigate the contribution of fatty acid beta-oxidation to the total energy budget of ovarian cancer cells.
Experimental procedures: Several ovarian cancer cells lines (OVKATE, OVSAHO, NIHOVCAR3) as well as a patient derived primary cell line (GD13-13P) were utilized for all experiments. The Seahorse Flux Analyzer in conjunction with several metabolic inhibitors including etomoxir (a carnitine palmitoyltransferase 1 inhibitor), 2-deoxy glucose, FCCP and rotenone were utilized in these experiments to evaluate the oxygen consumption rate(ORC) and extracellular acidification rate(ECAR) of cells at their basal and post metabolic inhibitor state. OCR and ECAR were used as markers for mitochondrial respiration and lactate production, respectively. NIHOVCAR3 cells were co-cultured with differentiated 3T3L1 adipocytes and then subjected to BODIPY fluorophore (493/503) fatty acid staining and confocal microscopy to investigate the potential relationship between ovarian cancer cells, adipocytes and metabolism.
Summary of data: All ovarian cancer cell lines demonstrated a significant decrease in their OCR with the administration of etomoxir (OVSAHO 78%, OVKATE 71%, NIHOVCAR 75%, GD13-13P 66%, p<0.001). The simultaneously measured ECAR was significantly increased in most cell lines (OVSAHO 62%, OVKATE 142%, GD13-13P 82%, p<0.001) after administration of etomoxir, while unchanged in the NIHOVCAR3 cell line. Metabolic activity was further evaluated by determining the effect administration of 2-deoxy glucose (2DG) had on the basal OCR and ECAR of OVKATE and OVSAHO cells. The basal OCR of both cell lines was essentially unchanged with the administration of 2DG; however a significant decrease was seen with the subsequent administration of etomoxir. The co-culture of NIHOVCAR3 cells and differentiated adipocytes resulted in a marked increase in visualization of BODIPY staining of cytoplasmic free fatty acids compared to NIHOVCAR3 cells grown without co-culture (control). The addition of the fatty acid synthase inhibitor orlistat to the culture media resulted in a marked decrease in the cytoplasmic staining of the control cells; however NIHOVCAR3 cells grown in co-culture had persistent cytoplasmic BODIPY staining.
Conclusions: These results suggest that ovarian cancer cell lines, as well as primary ovarian cancer cells, derive a significant portion of their energy from fatty acid beta oxidation, despite the presence of abundant glucose. Additionally, co-culture of ovarian cancer cells with adipocytes appears to provide ovarian cancer cells with exogenous free fatty acids donated by the adipocytes. These results help to further the concept that metastasis of ovarian cancer to fatty rich areas such as the omentum and mesentery may provide a metabolic advantage.
Citation Format: Karyn J. Hansen, Bennett Van Houten. Investigating fatty acid beta-oxidation in ovarian cancer cells [abstract]. In: Proceedings of the 10th Biennial Ovarian Cancer Research Symposium; Sep 8-9, 2014; Seattle, WA. Philadelphia (PA): AACR; Clin Cancer Res 2015;21(16 Suppl):Abstract nr POSTER-BIOL-1314.
American Association for Cancer Research (AACR)
Title: Abstract POSTER-BIOL-1314: Investigating fatty acid beta-oxidation in ovarian cancer cells
Description:
Abstract
Purpose: To investigate the contribution of fatty acid beta-oxidation to the total energy budget of ovarian cancer cells.
Experimental procedures: Several ovarian cancer cells lines (OVKATE, OVSAHO, NIHOVCAR3) as well as a patient derived primary cell line (GD13-13P) were utilized for all experiments.
The Seahorse Flux Analyzer in conjunction with several metabolic inhibitors including etomoxir (a carnitine palmitoyltransferase 1 inhibitor), 2-deoxy glucose, FCCP and rotenone were utilized in these experiments to evaluate the oxygen consumption rate(ORC) and extracellular acidification rate(ECAR) of cells at their basal and post metabolic inhibitor state.
OCR and ECAR were used as markers for mitochondrial respiration and lactate production, respectively.
NIHOVCAR3 cells were co-cultured with differentiated 3T3L1 adipocytes and then subjected to BODIPY fluorophore (493/503) fatty acid staining and confocal microscopy to investigate the potential relationship between ovarian cancer cells, adipocytes and metabolism.
Summary of data: All ovarian cancer cell lines demonstrated a significant decrease in their OCR with the administration of etomoxir (OVSAHO 78%, OVKATE 71%, NIHOVCAR 75%, GD13-13P 66%, p<0.
001).
The simultaneously measured ECAR was significantly increased in most cell lines (OVSAHO 62%, OVKATE 142%, GD13-13P 82%, p<0.
001) after administration of etomoxir, while unchanged in the NIHOVCAR3 cell line.
Metabolic activity was further evaluated by determining the effect administration of 2-deoxy glucose (2DG) had on the basal OCR and ECAR of OVKATE and OVSAHO cells.
The basal OCR of both cell lines was essentially unchanged with the administration of 2DG; however a significant decrease was seen with the subsequent administration of etomoxir.
The co-culture of NIHOVCAR3 cells and differentiated adipocytes resulted in a marked increase in visualization of BODIPY staining of cytoplasmic free fatty acids compared to NIHOVCAR3 cells grown without co-culture (control).
The addition of the fatty acid synthase inhibitor orlistat to the culture media resulted in a marked decrease in the cytoplasmic staining of the control cells; however NIHOVCAR3 cells grown in co-culture had persistent cytoplasmic BODIPY staining.
Conclusions: These results suggest that ovarian cancer cell lines, as well as primary ovarian cancer cells, derive a significant portion of their energy from fatty acid beta oxidation, despite the presence of abundant glucose.
Additionally, co-culture of ovarian cancer cells with adipocytes appears to provide ovarian cancer cells with exogenous free fatty acids donated by the adipocytes.
These results help to further the concept that metastasis of ovarian cancer to fatty rich areas such as the omentum and mesentery may provide a metabolic advantage.
Citation Format: Karyn J.
Hansen, Bennett Van Houten.
Investigating fatty acid beta-oxidation in ovarian cancer cells [abstract].
In: Proceedings of the 10th Biennial Ovarian Cancer Research Symposium; Sep 8-9, 2014; Seattle, WA.
Philadelphia (PA): AACR; Clin Cancer Res 2015;21(16 Suppl):Abstract nr POSTER-BIOL-1314.
Related Results
Abstract IA31: Molecular epidemiology of ovarian cancer
Abstract IA31: Molecular epidemiology of ovarian cancer
Abstract
Epithelial ovarian cancer (EOC) accounts for 5% of all cancer deaths and is the fifth leading cause of cancer death in women in the United States. While the...
Abstract B8: Molecular subtyping of epithelial ovarian cancer reveals connections to intrinsic breast cancer subtypes
Abstract B8: Molecular subtyping of epithelial ovarian cancer reveals connections to intrinsic breast cancer subtypes
Abstract
Aim: Epithelial ovarian cancer is one of the most lethal female cancers. It is a heterogeneous group of neoplasms and the different histologic subtypes are ...
Abstract A65: Snail, a potent inducer of global DNA methylation in ovarian cancer
Abstract A65: Snail, a potent inducer of global DNA methylation in ovarian cancer
Abstract
Snail plays a critical role in the epithelial to mesenchymal transition (EMT). To investigate the role of Snail in this event, we established inducible Snai...
Abstract POSTER-BIOL-1344: Epigenetic regulation of SPARC in ovarian cancer
Abstract POSTER-BIOL-1344: Epigenetic regulation of SPARC in ovarian cancer
Abstract
Background: We have previously reported the tumor suppressor effect of Secreted protein acidic and rich in cysteine (SPARC) in ovarian cancer in vitro and i...
Abstract 1501: Sideroflexin4: A novel regulator of iron metabolism in ovarian cancer
Abstract 1501: Sideroflexin4: A novel regulator of iron metabolism in ovarian cancer
Abstract
The five year survival rate for women with ovarian cancer is 9-34%. This high mortality is due to late stage diagnosis, marginally effective treatment and f...
Role of T cell receptor V beta genes in Theiler's virus-induced demyelination of mice.
Role of T cell receptor V beta genes in Theiler's virus-induced demyelination of mice.
Abstract
Intracerebral infection of certain strains of mice with Theiler's virus results in chronic immune-mediated demyelination in spinal cord. We used mouse mutan...
Abstract 1761: Dual inhibition of HSP27 and FAO as a novel therapeutic strategy for cisplatin-resistant ovarian cancer
Abstract 1761: Dual inhibition of HSP27 and FAO as a novel therapeutic strategy for cisplatin-resistant ovarian cancer
Abstract
Cisplatin is the most commonly employed chemotherapeutic drug for ovarian cancer treatment. However, most ovarian cancer patients experience recurrent cispl...
Abstract 875: PAX8 protein detection in serum of patients with serous ovarian cancer
Abstract 875: PAX8 protein detection in serum of patients with serous ovarian cancer
Abstract
Introduction: The paired-box (PAX) genes encode a family of transcription factors (TFs) with critical roles in the formation of tissues and organs during em...

